Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

Molecular replacement with MOLREP.

Vagin A, Teplyakov A.

Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):22-5. doi: 10.1107/S0907444909042589. Epub 2009 Dec 21.

PMID:
20057045
[PubMed - indexed for MEDLINE]
2.

X-ray crystallographic structure of the Norwalk virus protease at 1.5-A resolution.

Zeitler CE, Estes MK, Venkataram Prasad BV.

J Virol. 2006 May;80(10):5050-8.

PMID:
16641296
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Scaling and assessment of data quality.

Evans P.

Acta Crystallogr D Biol Crystallogr. 2006 Jan;62(Pt 1):72-82. Epub 2005 Dec 14. Review.

PMID:
16369096
[PubMed - indexed for MEDLINE]
4.

The integration of macromolecular diffraction data.

Leslie AG.

Acta Crystallogr D Biol Crystallogr. 2006 Jan;62(Pt 1):48-57. Epub 2005 Dec 14. Review.

PMID:
16369093
[PubMed - indexed for MEDLINE]
5.

A norovirus protease structure provides insights into active and substrate binding site integrity.

Nakamura K, Someya Y, Kumasaka T, Ueno G, Yamamoto M, Sato T, Takeda N, Miyamura T, Tanaka N.

J Virol. 2005 Nov;79(21):13685-93.

PMID:
16227288
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The CCP4 suite: programs for protein crystallography.

Collaborative Computational Project, Number 4.

Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3.

PMID:
15299374
[PubMed]
7.

Calicivirus 3C-like proteinase inhibits cellular translation by cleavage of poly(A)-binding protein.

Kuyumcu-Martinez M, Belliot G, Sosnovtsev SV, Chang KO, Green KY, Lloyd RE.

J Virol. 2004 Aug;78(15):8172-82.

PMID:
15254188
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The 3' end of Norwalk virus mRNA contains determinants that regulate the expression and stability of the viral capsid protein VP1: a novel function for the VP2 protein.

Bertolotti-Ciarlet A, Crawford SE, Hutson AM, Estes MK.

J Virol. 2003 Nov;77(21):11603-15.

PMID:
14557646
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics.

Dragovich PS, Prins TJ, Zhou R, Johnson TO, Hua Y, Luu HT, Sakata SK, Brown EL, Maldonado FC, Tuntland T, Lee CA, Fuhrman SA, Zalman LS, Patick AK, Matthews DA, Wu EY, Guo M, Borer BC, Nayyar NK, Moran T, Chen L, Rejto PA, Rose PW, Guzman MC, Dovalsantos EZ, Lee S, McGee K, Mohajeri M, Liese A, Tao J, Kosa MB, Liu B, Batugo MR, Gleeson JP, Wu ZP, Liu J, Meador JW 3rd, Ferre RA.

J Med Chem. 2003 Oct 9;46(21):4572-85.

PMID:
14521419
[PubMed - indexed for MEDLINE]
10.

Identification of further proteolytic cleavage sites in the Southampton calicivirus polyprotein by expression of the viral protease in E. coli.

Liu BL, Viljoen GJ, Clarke IN, Lambden PR.

J Gen Virol. 1999 Feb;80 ( Pt 2):291-6.

PMID:
10073687
[PubMed - indexed for MEDLINE]
Free Article
11.

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studies.

Dragovich PS, Webber SE, Babine RE, Fuhrman SA, Patick AK, Matthews DA, Reich SH, Marakovits JT, Prins TJ, Zhou R, Tikhe J, Littlefield ES, Bleckman TM, Wallace MB, Little TL, Ford CE, Meador JW 3rd, Ferre RA, Brown EL, Binford SL, DeLisle DM, Worland ST.

J Med Chem. 1998 Jul 16;41(15):2819-34.

PMID:
9667971
[PubMed - indexed for MEDLINE]
12.

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 1. Michael acceptor structure-activity studies.

Dragovich PS, Webber SE, Babine RE, Fuhrman SA, Patick AK, Matthews DA, Lee CA, Reich SH, Prins TJ, Marakovits JT, Littlefield ES, Zhou R, Tikhe J, Ford CE, Wallace MB, Meador JW 3rd, Ferre RA, Brown EL, Binford SL, Harr JE, DeLisle DM, Worland ST.

J Med Chem. 1998 Jul 16;41(15):2806-18.

PMID:
9667970
[PubMed - indexed for MEDLINE]
13.

Solid-phase synthesis of peptide-4-nitroanilides.

Kaspari A, Schierhorn A, Schutkowski M.

Int J Pept Protein Res. 1996 Nov;48(5):486-94.

PMID:
8956082
[PubMed - indexed for MEDLINE]
14.

Inactivation of cysteine proteases.

Govardhan CP, Abeles RH.

Arch Biochem Biophys. 1996 Jun 1;330(1):110-4.

PMID:
8651683
[PubMed - indexed for MEDLINE]
15.

Polyprotein processing in Southampton virus: identification of 3C-like protease cleavage sites by in vitro mutagenesis.

Liu B, Clarke IN, Lambden PR.

J Virol. 1996 Apr;70(4):2605-10.

PMID:
8642693
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

A conserved sequence motif at the 5' terminus of the Southampton virus genome is characteristic of the Caliciviridae.

Lambden PR, Liu B, Clarke IN.

Virus Genes. 1995;10(2):149-52.

PMID:
8560774
[PubMed - indexed for MEDLINE]
17.

Sequence and genome organization of a human small round-structured (Norwalk-like) virus.

Lambden PR, Caul EO, Ashley CR, Clarke IN.

Science. 1993 Jan 22;259(5094):516-9.

PMID:
8380940
[PubMed - indexed for MEDLINE]
18.

Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein.

Matthews DA, Smith WW, Ferre RA, Condon B, Budahazi G, Sisson W, Villafranca JE, Janson CA, McElroy HE, Gribskov CL, et al.

Cell. 1994 Jun 3;77(5):761-71.

PMID:
7515772
[PubMed - indexed for MEDLINE]
19.

On the size of the active site in proteases. I. Papain.

Schechter I, Berger A.

Biochem Biophys Res Commun. 1967 Apr 20;27(2):157-62. No abstract available.

PMID:
6035483
[PubMed - indexed for MEDLINE]
20.

Solvent content of protein crystals.

Matthews BW.

J Mol Biol. 1968 Apr 28;33(2):491-7. No abstract available.

PMID:
5700707
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk